These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 35185385)
1. Glibenclamide Alleviates LPS-Induced Acute Lung Injury through NLRP3 Inflammasome Signaling Pathway. Yang J; Yang J; Huang X; Xiu H; Bai S; Li J; Cai Z; Chen Z; Zhang S; Zhang G Mediators Inflamm; 2022; 2022():8457010. PubMed ID: 35185385 [TBL] [Abstract][Full Text] [Related]
2. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation. Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158 [TBL] [Abstract][Full Text] [Related]
3. Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis. Shan M; Wan H; Ran L; Ye J; Xie W; Lu J; Hu X; Deng S; Zhang W; Chen M; Wang F; Guo Z Drug Des Devel Ther; 2024; 18():1369-1384. PubMed ID: 38681210 [TBL] [Abstract][Full Text] [Related]
4. Glibenclamide alleviates inflammation in oleic acid model of acute lung injury through NLRP3 inflammasome signaling pathway. Chen H; Ding Y; Chen W; Feng Y; Shi G Drug Des Devel Ther; 2019; 13():1545-1554. PubMed ID: 31123394 [No Abstract] [Full Text] [Related]
5. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury. Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237 [TBL] [Abstract][Full Text] [Related]
6. Total tanshinones protect against acute lung injury through the PLCγ2/NLRP3 inflammasome signaling pathway. Li X; Qiu H; Gan J; Liu Z; Yang S; Yuan R; Gao H J Ethnopharmacol; 2023 Oct; 314():116478. PubMed ID: 37121449 [TBL] [Abstract][Full Text] [Related]
7. Silencing of long non-coding RNA MEG3 alleviates lipopolysaccharide-induced acute lung injury by acting as a molecular sponge of microRNA-7b to modulate NLRP3. Liao H; Zhang S; Qiao J Aging (Albany NY); 2020 Aug; 12(20):20198-20211. PubMed ID: 32852284 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation. Jiang L; Zhang L; Kang K; Fei D; Gong R; Cao Y; Pan S; Zhao M; Zhao M Biomed Pharmacother; 2016 Dec; 84():130-138. PubMed ID: 27643555 [TBL] [Abstract][Full Text] [Related]
9. Andrographolide Derivative AL-1 Ameliorates LPS-induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome and Lung Permeability. Li T; Zhang C; Wei Y; Zhong H; Shan L; Yu P; Wang Y; Xu L Curr Pharm Des; 2022; 28(30):2508-2517. PubMed ID: 35909279 [TBL] [Abstract][Full Text] [Related]
10. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation. Liu T; Zhou Y; Li P; Duan JX; Liu YP; Sun GY; Wan L; Dong L; Fang X; Jiang JX; Guan CX Sci Rep; 2016 Dec; 6():39473. PubMed ID: 28004759 [TBL] [Abstract][Full Text] [Related]
12. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H Front Immunol; 2022; 13():846384. PubMed ID: 35281058 [TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages. Zhou Y; Zhang CY; Duan JX; Li Q; Yang HH; Sun CC; Zhang J; Luo XQ; Liu SK Biomed Pharmacother; 2020 Jan; 121():109596. PubMed ID: 31731193 [TBL] [Abstract][Full Text] [Related]
14. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway. Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012 [TBL] [Abstract][Full Text] [Related]
15. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation. Zhang H; Chen S; Zeng M; Lin D; Wang Y; Wen X; Xu C; Yang L; Fan X; Gong Y; Zhang H; Kong X Cell Physiol Biochem; 2018; 49(5):1918-1932. PubMed ID: 30235451 [TBL] [Abstract][Full Text] [Related]
16. [Mechanism of total glucosides of White Paeony Capsules in ameliorating acute lung injury based on NLRP3 inflammasome]. Xu YJ; Wang XL; Mu WQ; Wen JC; Wang Y; Xiu Y; Dong X; Li JJ; Zhan XY; Xiao XH; Bai ZF Zhongguo Zhong Yao Za Zhi; 2024 May; 49(10):2754-2765. PubMed ID: 38812176 [TBL] [Abstract][Full Text] [Related]
17. Aloperine alleviates lipopolysaccharide-induced acute lung injury by inhibiting NLRP3 inflammasome activation. Zeng J; Liu J; Huang JH; Fu SP; Wang XY; Xi C; Cui YR; Qu F Int Immunopharmacol; 2023 Jul; 120():110142. PubMed ID: 37210910 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of pulmonary microvascular endothelial cells barrier dysfunction induced by LPS: The roles of ceramides and the Txnip/NLRP3 inflammasome. Ouyang H; Wang Y; Wu J; Ji Y Microvasc Res; 2023 May; 147():104491. PubMed ID: 36709858 [TBL] [Abstract][Full Text] [Related]
19. Resveratrol alleviates acute lung injury in mice by promoting Pink1/Parkin-related mitophagy and inhibiting NLRP3 inflammasome activation. Wu D; Zhang H; Li F; Liu S; Wang Y; Zhang Z; Wang J; Wu Q Biochim Biophys Acta Gen Subj; 2024 Jul; 1868(7):130612. PubMed ID: 38626830 [TBL] [Abstract][Full Text] [Related]
20. Tangeretin attenuates acute lung injury in septic mice by inhibiting ROS-mediated NLRP3 inflammasome activation via regulating PLK1/AMPK/DRP1 signaling axis. Liu Y; Zhang Y; You G; Zheng D; He Z; Guo W; Antonina K; Shukhrat Z; Ding B; Zan J; Zhang Z Inflamm Res; 2024 Jan; 73(1):47-63. PubMed ID: 38147126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]